Study title

SLT for Open-Angle Glaucoma

Type

Retrospective

Number of patients

430

Primery investigator

Ivan Goldberg, Paul Healey 

Secondary investigators

Colin Chong
Stuart Graham, Paul Healey

Contact informaion

trials@eyeassociates.com.au 

Place

Eye Asscoiates

Town

Sydney

Country

Australia

Start date

 

Expected completion date

 

Expected publication date


Purpose

Retrospective review of medical records of patients generally on MTMT with IOPs > target repeated measures ANOVA, Kaplan-Meier and Cox Regression
Randomly selected one eye from each patient


method

Almost all patients had 360 degrees SLT  two divided sessions (180 degrees at a time)  adjust power to threshold for champagne bubbles  pre-treated with one drop each of – apraclonidine 1%  pilocarpine 2%  dexamethasone 0.1%
no post-SLT specific therapy –  continue usual anti-glaucoma medications

Preliminary Results

Appears to be safe, potentially repeatable and can be considered as an alternative treatment to ALT
Achieves target pressure 82% at 6 months
Efficacy decreases gradually to around 50% at 24 months
Useful option for patients on MTMT otherwise needing ALT or filtering surgery
prior cataract surgery diminishes likelihood of success

Conclusion

 

 

SLT for Open-Angle Glaucoma